Our portfolio

Advancion (formerly ANGUS Chemicals) develops and produces specialty additives utilized in premium Life Science and Industrial Technology applications, utilizing novel chemistries that enable cutting edge properties such as ultra-high purity, traceability, clean-labels, odor elimination, and extended longevity. Headquartered in Illinois, Advancion sells its products around the world and operates facilities in Louisiana and Germany.

Founded in 1999, Infoblox is the industry pioneer and market leader in DDI software, a sub-segment of IT network management. The company serves a wide array of customers globally, providing its core DDI solution primarily to large enterprises and some small/medium enterprise customers.

Founded in 2003, Syclef is a French leader in the installation and maintenance of refrigeration systems. The group is specialized in medium and large refrigeration installations, in industrial refrigeration (logistics platforms, storage warehouses, food processing...), commercial refrigeration (supermarkets, convenience stores...) and air conditioning. Syclef's customer base relies on Syclef to manage its complex and critical refrigeration systems. The group benefits from a key player position in the energy transition through the use of innovative "eco-responsible" technologies such as natural refrigerant fluids.

Maple Leaf is a battery storage portfolio composed of ten asset locations throughout Ontario and includes two separate 10 MW/20 MWh projects expected to reach commercial operations in 2021.
The vehicle company is 80% owned by Ardian Infrastructure and 20% by Enel X. Through the partnership, Enel X will continue to construct, operate, and maintain these projects and will be responsible for the development of future projects.

Acousti Engineering Company of Florida and its branches throughout the Southeastern United States provide specialty interior finish solutions, focusing on the installation of specialty ceilings and walls primarily into institutional, infrastructure and commercial end markets.

H2 Pharma is a privileged partner of all pharmaceutical companies for their generic or OTC products.
Today considered as the reference in the segment of non-sterile liquid pharmaceutical specialties (mouthwash, syrup, oral solution...), H2 Pharma has holistic control of the entire value chain. Its industrial practices, its innovation capacity in pharmaceutical flow and its cutting-edge technology enable H2 Pharma to differentiate itself.